New Insights on Chronotherapy in Hypertension: Is Timing Everything?

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2020 Mar 16

PMID 32172412

Citations 5

Authors

Christina Thoonkuzhy

Mahboob Rahman

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: With the wider availability and use of ambulatory blood pressure monitoring, there has been increasing interest in diurnal variations of blood pressure and its clinical significance. Nocturnal hypertension is of particular interest due to its predictive value in cardiovascular and all-cause mortality outcomes. The purpose of this paper is to review the clinical significance of nocturnal hypertension, summarize the literature regarding chronotherapy in hypertension, and explore the potential for nighttime dosing of antihypertensives to improve clinical outcomes.

Recent Findings: The results from current literature evaluating the effect of nighttime dosing of antihypertensive drugs on blood pressure are inconsistent, with some studies showing a substantial effect of nighttime administration of antihypertensive drugs on blood pressure, and others a more modest effect. Some clinical trials demonstrate a significant improvement in clinical outcomes with nighttime administration of antihypertensive medications and other large trials are currently in progress. Chronotherapy remains an important area of research in hypertension.

Citing Articles

Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review.

Javaheri S, Javaheri S, Somers V, Gozal D, Mokhlesi B, Mehra R J Am Coll Cardiol. 2024; 84(13):1208-1223.

PMID: 39293884 PMC: 11666391. DOI: 10.1016/j.jacc.2024.02.059.

Demonstrating the Benefits of Antihypertensive Nighttime Dosing and Indapamide Usage in Hypertension Management.

Newsome J J Pharm Technol. 2024; 40(1):10-14.

PMID: 38318257 PMC: 10838540. DOI: 10.1177/87551225231207275.

The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized,....

Xu M, Zhang X, Ye R, Liu X, Sun L, Jia S Trials. 2023; 24(1):770.

PMID: 38017457 PMC: 10685633. DOI: 10.1186/s13063-023-07726-x.

Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect.

Habas Sr E, Akbar R, Alfitori G, Farfar K, Habas E, Errayes N Cureus. 2023; 15(7):e42681.

PMID: 37649932 PMC: 10464654. DOI: 10.7759/cureus.42681.

Night-Time Non-dipping Blood Pressure and Heart Rate: An Association With the Risk of Silent Small Vessel Disease in Patients Presenting With Acute Ischemic Stroke.

Akhtar N, Al-Jerdi S, Kamran S, Singh R, Babu B, Abdelmoneim M Front Neurol. 2021; 12:719311.

PMID: 34867710 PMC: 8637909. DOI: 10.3389/fneur.2021.719311.

References

Hermida R, Ayala D, Mojon A, Fernandez J . Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010; 27(8):1629-51. DOI: 10.3109/07420528.2010.510230. View

Sogunuru G, Kario K, Shin J, Chen C, Buranakitjaroen P, Chia Y . Morning surge in blood pressure and blood pressure variability in Asia: Evidence and statement from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2018; 21(2):324-334. PMC: 8030409. DOI: 10.1111/jch.13451. View

Rorie D, Rogers A, Mackenzie I, Ford I, Webb D, Willams B . Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study. BMJ Open. 2016; 6(2):e010313. PMC: 4762112. DOI: 10.1136/bmjopen-2015-010313. View

Lurbe E, Redon J, Kesani A, Pascual J, Tacons J, Alvarez V . Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002; 347(11):797-805. DOI: 10.1056/NEJMoa013410. View

Roush G, Fapohunda J, Kostis J . Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 2014; 16(8):561-8. PMC: 8031640. DOI: 10.1111/jch.12354. View

Polonsky T, Bakris G . Ambulatory Blood Pressure Monitoring. JAMA. 2018; 320(17):1807-1808. DOI: 10.1001/jama.2018.14856. View

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3):145-53. DOI: 10.1056/NEJM200001203420301. View

Kario K . Nocturnal Hypertension: New Technology and Evidence. Hypertension. 2018; 71(6):997-1009. DOI: 10.1161/HYPERTENSIONAHA.118.10971. View

Cuspidi C, Facchetti R, Bombelli M, Sala C, Negri F, Grassi G . Nighttime blood pressure and new-onset left ventricular hypertrophy: findings from the Pamela population. Hypertension. 2013; 62(1):78-84. DOI: 10.1161/HYPERTENSIONAHA.111.00682. View

10.

Serinel Y, Yee B, Grunstein R, Wong K, Cistulli P, Arima H . Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial. Thorax. 2016; 72(6):550-558. DOI: 10.1136/thoraxjnl-2016-209504. View

11.

Hansen T, Li Y, Boggia J, Thijs L, Richart T, Staessen J . Predictive role of the nighttime blood pressure. Hypertension. 2010; 57(1):3-10. DOI: 10.1161/HYPERTENSIONAHA.109.133900. View

12.

Cheng H, Wu C, Sung S, Lee J, Kario K, Chiang C . Prognostic Utility of Morning Blood Pressure Surge for 20-Year All-Cause and Cardiovascular Mortalities: Results of a Community-Based Study. J Am Heart Assoc. 2017; 6(12). PMC: 5779060. DOI: 10.1161/JAHA.117.007667. View

13.

Laffin L, Bakris G . Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension?. Hypertension. 2018; 72(4):836-838. PMC: 6289950. DOI: 10.1161/HYPERTENSIONAHA.118.11207. View

14.

Drawz P, Alper A, Anderson A, Brecklin C, Charleston J, Chen J . Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clin J Am Soc Nephrol. 2016; 11(4):642-52. PMC: 4822674. DOI: 10.2215/CJN.08530815. View

15.

Morgan T, Anderson A, Jones E . The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997; 15(2):205-11. DOI: 10.1097/00004872-199715020-00012. View

16.

Bilo G, Grillo A, Guida V, Parati G . Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects. Integr Blood Press Control. 2018; 11:47-56. PMC: 5973439. DOI: 10.2147/IBPC.S130277. View

17.

Stergiou G, Kario K, Kollias A, McManus R, Ohkubo T, Parati G . Home blood pressure monitoring in the 21st century. J Clin Hypertens (Greenwich). 2018; 20(7):1116-1121. PMC: 8030885. DOI: 10.1111/jch.13284. View

18.

Yan B, Peng L, Han D, Sun L, Dong Q, Yang P . Blood pressure reverse-dipping is associated with early formation of carotid plaque in senior hypertensive patients. Medicine (Baltimore). 2015; 94(10):e604. PMC: 4602459. DOI: 10.1097/MD.0000000000000604. View

19.

Rahman M, Greene T, Phillips R, Agodoa L, Bakris G, Charleston J . A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension. 2012; 61(1):82-8. PMC: 3523681. DOI: 10.1161/HYPERTENSIONAHA.112.200477. View

20.

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105-87. DOI: 10.1097/HJH.0b013e3281fc975a. View